Findings from this study are poised to have a remarkable impact on treatment for ulcerative colitis and IBD overall. The investigational therapy was generated based on the concept of precision ...
Widjaja Inflammatory Bowel Disease Institute at Cedars-Sinai. "The investigational therapy was generated based on the concept of precision medicine; it shows promise as being both anti ...
Ulcerative colitis is a chronic condition characterized ... approaches to help people who have not responded to conventional therapy. Study author Bruce E. Sands, MD, MS, with the Division of ...
Analysts have suggested that TL1A inhibitors could have blockbuster sales potential as second-line therapy for IBD refractory to first-line TNF biologics, with plenty of upside if they move into ...